Norwest Venture Partners is a venture capital and growth equity investment firm founded in 1961 and based in Palo Alto, California. The firm specializes in early to late-stage investments across a diverse range of sectors, including technology, healthcare, consumer products, and business services. Norwest has invested in over 600 companies and currently partners with more than 140 active firms within its portfolio. The firm focuses on providing capital to companies in the United States, India, and Israel, investing amounts typically ranging from $1 million to $30 million for early-stage companies and $15 million to $100 million for growth equity investments. With a strong emphasis on helping CEOs and founders scale their businesses, Norwest leverages its extensive network and operational expertise to support the companies in which it invests.
Principal, Head of Mergers Acquisitions and Capital Markets
Yoni Braun
Vice President
Sonya Brown
General Partner and Co-Head of Growth Equity
Shiv Chaudhary
Managing Director
Priti Youssef Choksi
Partner
Casper De Clercq
General Partner
Nathan Cohen
Vice President
Jeffrey Crowe
Co-Founder and Senior Managing Partner
Ran Ding
Partner
Matthew De Dominicis
Partner and CFO
Philip Fleischman
Vice President
David Glaser
Investor
Anubha Goyal
Investor, Norwest India
Ken Graham
Investor
Aidan Greenstein
Investor
Guillermo Grimaldo
Investor
Garrett Hardesty
Investor
Ryan Harris
General Partner
Sean Jacobsohn
Partner
Trey Jennings
Senior Associate
Krish Kapadia
Vice President
Sameer Kapur
Vice President, Growth Equity
Paul Kigawa
Investor
Nikhil Kookada
Vice President
Jon Kossow
Co-Founder and Managing Partner
Parul Laddha
Investor, Norwest India
Jordan Leites
Vice President
Sam Lesser
Investor
Sonia Li
Associate
Brian Matesic
Principal
Cassie McHenry
Investor
JP McKeever
Investor
John McNeil
Investor
Ryan McDonald
Principal - Healthcare
Venkat Mohan
Operating Partner and Board Member
Brian Moon
Senior Associate
Dror Nahumi
General Partner
Michelle Nie
Investor
Ginny Pan
Investor
Connor Pike
Principal, Growth Equity
Ankit Prasad
Vice President
Irem Rami
Principal, Growth Equity and Venture
Ashwin Ravi
Associate
Gabrielle Rush
Investor
Samuel Saldarriaga
Investor
Umang Sanghvi
Investor, Norwest India
Christopher Scullin
Vice President
Rama Sekhar
Partner
Suraj Shah
Vice President
Niren Shah
Managing Director and Head of India, Norwest Venture Partners (NVP) India
Chris Sondej
Principal, Growth Equity
Gabe Stauber
Associate
Laurie Tennant
Principal, People Advisory
Matthew Uthupan
Investor
Sanchana Vasikaran
Investor
Vidushi Verma
Investor, Norwest India
Jessica Yi
Vice President
Edward Yip
Partner
Michael Zarian
Investor
Justin Zhang
Investor
David Zilberman
General Partner
Dave Zilberman
General Partner
Past deals in Florida
Zenas BioPharma
Series C in 2024
Zenas BioPharma is a clinical-stage biopharmaceutical company based in Florida, dedicated to developing immune-based therapies for patients. The company's lead product candidate, obexelimab, is a bifunctional monoclonal antibody that targets both CD19 and FcγRIIb, which are found on B cells. This innovative approach aims to inhibit the activity of B cells involved in various autoimmune diseases while preserving their overall population, thus offering a potential therapeutic advantage over traditional treatments that deplete these cells.
Aesthetic Partners
Private Equity Round in 2023
Aesthetic Partners is a clinical aesthetics practice management firm established in 2018 and based in Miami, Florida. The firm specializes in acquiring and partnering with high-end, physician-led medical aesthetics, cosmetic dermatology, and plastic surgery clinics across the United States. Aesthetic Partners focuses on supporting its portfolio brands through financial investment, operational expertise, and assistance with expanding their locations, ensuring a patient-centric approach in all endeavors.
Neocis
Series D in 2022
Neocis, Inc. is a Miami-based company that specializes in robotic guidance systems for dental implant procedures. Founded in 2009, Neocis develops the Yomi system, a robotic device designed to enhance the precision of dental surgeries. Yomi integrates computer imagery from CT scans with surgical planning, providing dental surgeons with multi-sensory feedback during procedures. This technology aims to transform dental surgery by offering a minimally invasive approach, which can lead to faster recovery times for patients. The Yomi system has received clearance from the U.S. Food and Drug Administration and is commercially available in the United States, underscoring Neocis's commitment to advancing patient care and addressing the challenges faced by dental professionals.
Neocis
Series D in 2020
Neocis, Inc. is a Miami-based company that specializes in robotic guidance systems for dental implant procedures. Founded in 2009, Neocis develops the Yomi system, a robotic device designed to enhance the precision of dental surgeries. Yomi integrates computer imagery from CT scans with surgical planning, providing dental surgeons with multi-sensory feedback during procedures. This technology aims to transform dental surgery by offering a minimally invasive approach, which can lead to faster recovery times for patients. The Yomi system has received clearance from the U.S. Food and Drug Administration and is commercially available in the United States, underscoring Neocis's commitment to advancing patient care and addressing the challenges faced by dental professionals.
Neocis
Venture Round in 2019
Neocis, Inc. is a Miami-based company that specializes in robotic guidance systems for dental implant procedures. Founded in 2009, Neocis develops the Yomi system, a robotic device designed to enhance the precision of dental surgeries. Yomi integrates computer imagery from CT scans with surgical planning, providing dental surgeons with multi-sensory feedback during procedures. This technology aims to transform dental surgery by offering a minimally invasive approach, which can lead to faster recovery times for patients. The Yomi system has received clearance from the U.S. Food and Drug Administration and is commercially available in the United States, underscoring Neocis's commitment to advancing patient care and addressing the challenges faced by dental professionals.
Carecloud
Series C in 2016
CareCloud Corporation is a healthcare information technology company based in Miami, Florida, founded in 2009. It specializes in cloud-based solutions, offering a comprehensive suite of services that includes practice management, electronic health records, revenue cycle management, and patient engagement tools. CareCloud caters to various medical specialties such as dermatology, family practice, ophthalmology, podiatry, rheumatology, and urology. By leveraging its innovative software-as-a-service platforms, the company aims to enhance profitability, streamline workflows, and improve patient care for medical groups across the United States. CareCloud's data-driven tools provide actionable insights, facilitating effective management of the financial and administrative aspects of healthcare delivery. The company currently manages over $4 billion in annualized accounts receivable on its integrated clinical and financial platform. As of early 2020, CareCloud operates as a subsidiary of MTBC, Inc.
Carecloud
Series B in 2013
CareCloud Corporation is a healthcare information technology company based in Miami, Florida, founded in 2009. It specializes in cloud-based solutions, offering a comprehensive suite of services that includes practice management, electronic health records, revenue cycle management, and patient engagement tools. CareCloud caters to various medical specialties such as dermatology, family practice, ophthalmology, podiatry, rheumatology, and urology. By leveraging its innovative software-as-a-service platforms, the company aims to enhance profitability, streamline workflows, and improve patient care for medical groups across the United States. CareCloud's data-driven tools provide actionable insights, facilitating effective management of the financial and administrative aspects of healthcare delivery. The company currently manages over $4 billion in annualized accounts receivable on its integrated clinical and financial platform. As of early 2020, CareCloud operates as a subsidiary of MTBC, Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.